Cellular Chitchatting: Exploring the Role of Exosomes as Cardiovascular Risk Factors.

atherosclerosis cardiovascular disease diabetes exercice exosomes

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2022
Historique:
received: 22 01 2022
accepted: 16 03 2022
entrez: 18 4 2022
pubmed: 19 4 2022
medline: 19 4 2022
Statut: epublish

Résumé

Exosomes are small bi-lipid membranous vesicles (30-150 nm) containing different biological material such as proteins, lipids and nucleic acid. These small vesicles, inducing a cell to cell signaling pathway, are able to mediate multidirectional crosstalk to maintain homeostasis or modulate disease processes. With their various contents, exosomes sort and transfer specific information from their origin to a recipient cell, from a tissue or organ in the close proximity or at distance, generating an intra-inter tissue or organ communication. In the last decade exosomes have been identified in multiple organs and fluids under different pathological conditions. In particular, while the content and the abundance of exosome is now a diagnostic marker for cardiovascular diseases, their role in context-specific physiological and pathophysiological conditions in the cardiovascular system remains largely unknown. We summarize here the current knowledge on the role of exosomes as mediators of cardiovascular diseases in several pathophysiological conditions such as atherosclerosis and diabetes. In addition, we describe evidence of intercellular connection among multiple cell type (cardiac, vasculature, immune cells) as well as the challenge of their

Identifiants

pubmed: 35433670
doi: 10.3389/fcell.2022.860005
pii: 860005
pmc: PMC9008366
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

860005

Informations de copyright

Copyright © 2022 Germena, Zelarayán and Hinkel.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Rev Endocrinol. 2016 Sep;12(9):504-17
pubmed: 27230949
Mol Med Rep. 2018 Jul;18(1):509-515
pubmed: 29750307
Nat Cell Biol. 2012 Feb 12;14(3):249-56
pubmed: 22327366
Clin Exp Pharmacol Physiol. 2009 Feb;36(2):181-8
pubmed: 18986336
J Mol Cell Cardiol. 2015 Dec;89(Pt B):268-79
pubmed: 26497614
Int J Immunopathol Pharmacol. 2003 Sep-Dec;16(3):225-31
pubmed: 14611725
J Extracell Vesicles. 2015 Jul 02;4:28239
pubmed: 26142461
J Extracell Vesicles. 2021 Apr;10(6):12084
pubmed: 33936566
Front Pharmacol. 2021 Nov 26;12:785220
pubmed: 34899348
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
Theranostics. 2018 Mar 8;8(8):2171-2188
pubmed: 29721071
Diabetologia. 2018 May;61(5):1124-1134
pubmed: 29445851
J Cell Biochem. 2018 Nov;119(11):9433-9443
pubmed: 30074271
Diabetes. 1996 Jul;45(7):926-33
pubmed: 8666144
J Sport Health Sci. 2021 Oct 1;:
pubmed: 34606978
Thromb Haemost. 2011 Nov;106(5):827-38
pubmed: 22012554
PLoS One. 2014 Sep 09;9(9):e106153
pubmed: 25203514
Diabetes. 2019 Mar;68(3):515-526
pubmed: 30552111
Eur J Immunol. 2014 Apr;44(4):1156-69
pubmed: 24338844
J Clin Invest. 2014 May;124(5):2136-46
pubmed: 24743145
Front Immunol. 2019 Oct 02;10:2205
pubmed: 31632389
Diabetes. 2016 Oct;65(10):3111-28
pubmed: 27284111
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28490541
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Sci Rep. 2016 Oct 21;6:35562
pubmed: 27765945
J Clin Invest. 1998 Jul 1;102(1):136-44
pubmed: 9649567
Dev Cell. 2011 Oct 18;21(4):708-21
pubmed: 21962903
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Front Immunol. 2014 Aug 20;5:403
pubmed: 25191326
Biomark Res. 2021 Mar 12;9(1):18
pubmed: 33712063
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Cell Commun Signal. 2021 Apr 23;19(1):47
pubmed: 33892745
FASEB Bioadv. 2021 Mar 04;3(6):399-406
pubmed: 34124595
Diabetes. 2017 Feb;66(2):460-473
pubmed: 27872147
Theranostics. 2018 Jan 1;8(1):237-255
pubmed: 29290805
Cell Rep. 2020 Jul 14;32(2):107881
pubmed: 32668250
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30335-30343
pubmed: 33199621
Front Cardiovasc Med. 2021 Apr 23;8:676267
pubmed: 33969024
Am J Physiol Cell Physiol. 2007 May;292(5):C1799-808
pubmed: 17229813
Am J Transl Res. 2018 Dec 15;10(12):4350-4366
pubmed: 30662677
Heliyon. 2019 Oct 21;5(10):e02633
pubmed: 31687497
Cell Biol Int. 2021 Jun;45(6):1191-1201
pubmed: 33501735
Fundam Clin Pharmacol. 2011 Dec;25(6):653-60
pubmed: 21105910
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):482-90
pubmed: 26821950
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):49-63
pubmed: 28882869
Biotechnol Lett. 2020 Aug;42(8):1597-1610
pubmed: 32430801
Diabetes. 2003 May;52(5):1128-36
pubmed: 12716742
J Physiol. 2011 Aug 15;589(Pt 16):3983-94
pubmed: 21690193
Cell Cycle. 2019 Oct;18(20):2674-2684
pubmed: 31416388
Diabetes. 2018 Nov;67(11):2377-2388
pubmed: 29720498
Cell Commun Signal. 2021 Oct 7;19(1):100
pubmed: 34620169
J Int Med Res. 2017 Dec;45(6):1901-1929
pubmed: 28643578
Free Radic Biol Med. 2015 Sep;86:352-61
pubmed: 26117319
FASEB J. 2016 Sep;30(9):3097-106
pubmed: 27226520
Scand J Immunol. 2018 Apr;87(4):e12648
pubmed: 29465752
J Control Release. 2016 Sep 28;238:166-175
pubmed: 27475298
Nat Med. 2021 Jan;27(1):49-57
pubmed: 33398163
J Mol Cell Cardiol. 2014 Sep;74:139-50
pubmed: 24825548
Cell Biosci. 2021 Jan 15;11(1):19
pubmed: 33451365
Cardiovasc Res. 2018 Jan 1;114(1):19-34
pubmed: 29106545
Curr Pharm Biotechnol. 2012 Oct;13(13):2435-9
pubmed: 22280417
Semin Cancer Biol. 2014 Oct;28:3-13
pubmed: 24769058
Cell Metab. 2019 Feb 5;29(2):348-361.e6
pubmed: 30318337
Korean Diabetes J. 2010 Aug;34(4):222-8
pubmed: 20835339
Circulation. 2010 Aug 31;122(9):928-37
pubmed: 20805439
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12158-12163
pubmed: 30429322
Cell. 2017 Oct 5;171(2):372-384.e12
pubmed: 28942920
Biochem Cell Biol. 2021 Dec;99(6):693-699
pubmed: 34726968
Circulation. 2004 Jan 20;109(2):220-6
pubmed: 14691039
Front Immunol. 2018 Aug 06;9:1789
pubmed: 30131806
J Immunol. 2011 Aug 15;187(4):1591-600
pubmed: 21734072
J Cell Mol Med. 2015 Sep;19(9):2153-61
pubmed: 25824442
Cell Death Differ. 2009 Jan;16(1):70-8
pubmed: 19008921
Circulation. 2015 Jun 16;131(24):2120-30
pubmed: 25995315
Cell Biosci. 2020 Aug 1;10:92
pubmed: 32765827
J Transl Med. 2021 May 8;19(1):196
pubmed: 33964940
Cardiovasc J Afr. 2012 May;23(4):222-31
pubmed: 22614668
Thromb Res. 2017 Jun;154:96-105
pubmed: 28460288
Trends Mol Med. 2021 Mar;27(3):248-262
pubmed: 33139169
Traffic. 2009 Jul;10(7):925-37
pubmed: 19490536
Circ Res. 2019 Apr 26;124(9):1386-1400
pubmed: 30879399

Auteurs

Giulia Germena (G)

Laboratory Animal Science Unit, Leibniz-Institut für Primatenforschung, Deutsches Primatenzentrum GmbH, Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.

Laura Cecilia Zelarayán (LC)

DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.
Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.

Rabea Hinkel (R)

Laboratory Animal Science Unit, Leibniz-Institut für Primatenforschung, Deutsches Primatenzentrum GmbH, Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.
Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour (ITTN), Stiftung Tierärztliche Hochschule Hannover, University of Veterinary Medicine, Hannover, Germany.

Classifications MeSH